Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon ...

In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly ...

Aerosol Delivery Devices Market Research Report In 2019, the aerosol delivery devices market is projected to reach $46.73 billion by 2027, ...

Respiratory nurse lead Carol Stonham outlines what nurses in primary care need to know about changes in the diagnosis and ...

3 Clinical physiology and nuclear medicine, Tampere University Hospital, Tampere, Finland 4 Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland Sufficient peak inspiratory ...

Afrezza delivers inhaled insulin using the Gen2 inhaler for the treatment of patients with type 1 and type 2 Diabetes. Afrezza was evaluated in long-term nonclinical pulmonary safety studies in 2 ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, Arizona lawsuit says ...

At the same time, sodium cromoglycate was introduced, to be administered via the first dry-powder inhaler — the Spinhaler — but owing to its relatively weak anti-inflammatory action its use is ...

And while other options exist like dry-powder inhalers and soft mist inhalers, MDIs are still the best option for many patients for a variety of reasons, according to AstraZeneca. AstraZeneca and ...

Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic ...

Innovations such as dry powder inhalers, soft mist inhalers, and metered-dose inhalers are making it easier for patients to manage their dosage and achieve optimal therapeutic effects. Moreover ...